The percentages of Tph1 and Tph2 cells were significantly higher in SLE patients with cutaneous manifestation, musculoskeletal manifestation, serositis, or fever when compared with patients without each manifestation (Fig. 6a, Supplementary Table 7). The gene discussed is TPH2; the disease is systemic lupus erythematosus.